New Toolkit Helps Community Pharmacies Launch Harm Reduction Services
A new toolkit from the University of Pittsburgh School of Pharmacy offers community pharmacies a practical, step-by-step guide to implementing harm reduction services — from assembling supply kits and training staff to marketing services and integrating them into existing workflows. Here's why it matters for pharmacist-led OUD care.
How Pharmacists Could Be Key to Addressing the Opioid Crisis
Optimal adherence to long-acting injectable buprenorphine (BUP-XR or Sublocade®) for opioid use disorder saves $15,017 per patient annually by drastically reducing costly emergency department visits and detoxification events. This research supports the economic benefits of paying community pharmacists to administer long-acting injections, effectively improving treatment access while lowering overall healthcare spending.